Copper chelation as targeted therapy in a genetic mouse model of oncogenic BRAF-driven thyroid cancer.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Duke University, Duke Medical Center, Duke Cancer Institute
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890714902
